Literature DB >> 22080494

Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Paolo Fusar-Poli1, Joaquim Radua, Philip McGuire, Stefan Borgwardt.   

Abstract

BACKGROUND: Despite impressive advancements in early interventions in psychosis, there is an urgent need of robust neurobiological markers to improve the predictive value of psychosis transition. Available structural imaging literature in the field is undermined by several methodological caveats and a number of confounders such as exposure to antipsychotic treatment.
METHODS: Fourteen voxel-based morphometry studies of antipsychotic-naive subjects at enhanced clinical risk for psychosis (high risk [HR]) or experiencing a first-episode psychosis (FEP) were included. Formal meta-analysis of effect sizes and "signed differential mapping" voxel-based meta-analysis were combined to control the results for sample sizes, strength of individual findings, and confounding variables.
RESULTS: Formal effect size meta-analysis indicated consistent gray matter (GM) reductions both in subjects at enhanced clinical risk for psychosis and in first-episode subjects when compared with control groups. Voxel-based meta-analysis showed GM reductions in the temporal, limbic prefrontal cortex within the HR group and in the temporal insular cortex and cerebellum within the FEP group. Psychosis onset was characterized by GM decreases in temporal, anterior cingulate, cerebellar, and insular regions. GM alterations in the temporal regions directly related to severity of psychotic symptoms. There was no publication bias. Heterogeneity across studies was low. Sensitivity analyses confirmed robustness of the above results.
CONCLUSIONS: Vulnerability to psychosis is associated with consistent GM decreases in prefrontal and temporolimbic areas. The onset of full disease is accompanied by temporoinsular, anterior cingulate, and cerebellar GM reductions. Neuroanatomical alterations in temporal regions may underlie the clinical onset of psychotic symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 22080494      PMCID: PMC3494061          DOI: 10.1093/schbul/sbr134

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  57 in total

1.  Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis.

Authors:  Tsutomu Takahashi; Stephen J Wood; Alison R Yung; Lisa J Phillips; Bridget Soulsby; Patrick D McGorry; Ryoichiro Tanino; Shi-Yu Zhou; Michio Suzuki; Dennis Velakoulis; Christos Pantelis
Journal:  Schizophr Res       Date:  2009-04-05       Impact factor: 4.939

Review 2.  Superior temporal gyrus volume change in schizophrenia: a review on region of interest volumetric studies.

Authors:  Jinhua Sun; Jerome J Maller; Lanting Guo; Paul B Fitzgerald
Journal:  Brain Res Rev       Date:  2009-04-05

Review 3.  Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology.

Authors:  Alex Fornito; Murat Yücel; Brian Dean; Stephen J Wood; Christos Pantelis
Journal:  Schizophr Bull       Date:  2008-04-23       Impact factor: 9.306

Review 4.  The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?--a systematic review.

Authors:  R Smieskova; P Fusar-Poli; P Allen; K Bendfeldt; R D Stieglitz; J Drewe; E W Radue; P K McGuire; A Riecher-Rössler; S J Borgwardt
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 5.  Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder.

Authors:  Joaquim Radua; David Mataix-Cols
Journal:  Br J Psychiatry       Date:  2009-11       Impact factor: 9.319

6.  Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study.

Authors:  Emmanuel Stip; Adham Mancini-Marïe; Geneviève Letourneau; Chérine Fahim; Boualem Mensour; Fabrice Crivello; Sonia Dollfus
Journal:  Int Clin Psychopharmacol       Date:  2009-01       Impact factor: 1.659

7.  Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up.

Authors:  Alison R Yung; Barnaby Nelson; Carrie Stanford; Magenta B Simmons; Elizabeth M Cosgrave; Eoin Killackey; Lisa J Phillips; Andreas Bechdolf; Joe Buckby; Patrick D McGorry
Journal:  Schizophr Res       Date:  2008-09-02       Impact factor: 4.939

8.  Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.

Authors:  Tsutomu Takahashi; Stephen J Wood; Alison R Yung; Bridget Soulsby; Patrick D McGorry; Michio Suzuki; Yasuhiro Kawasaki; Lisa J Phillips; Dennis Velakoulis; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2009-04

9.  Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.

Authors:  Anna Mané; Carles Falcon; J Javier Mateos; Emilio Fernandez-Egea; Guillermo Horga; Francisco Lomeña; Nuria Bargalló; Alberto Prats-Galino; Miguel Bernardo; Eduard Parellada
Journal:  Schizophr Res       Date:  2009-08-15       Impact factor: 4.939

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  101 in total

1.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

2.  Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review.

Authors:  Jessica A Wojtalik; Shaun M Eack; Matthew J Smith; Matcheri S Keshavan
Journal:  J Soc Social Work Res       Date:  2018-04-27

Review 3.  Attenuated psychosis syndrome in DSM-5.

Authors:  Ming T Tsuang; Jim Van Os; Rajiv Tandon; Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel E Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; William Carpenter
Journal:  Schizophr Res       Date:  2013-06-14       Impact factor: 4.939

4.  Impaired context processing as a potential marker of psychosis risk state.

Authors:  Tara A Niendam; Tyler A Lesh; Jong Yoon; Andrew J Westphal; Natalie Hutchison; J Daniel Ragland; Marjorie Solomon; Michael Minzenberg; Cameron S Carter
Journal:  Psychiatry Res       Date:  2013-10-11       Impact factor: 3.222

Review 5.  Antipsychotic interventions in prodromal psychosis: safety issues.

Authors:  Chen-Chung Liu; Arsime Demjaha
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

6.  Midline Brain Abnormalities Across Psychotic and Mood Disorders.

Authors:  Ramón Landin-Romero; Benedikt L Amann; Salvador Sarró; Amalia Guerrero-Pedraza; Victor Vicens; Elena Rodriguez-Cano; Eduard Vieta; Raymond Salvador; Edith Pomarol-Clotet; Joaquim Radua
Journal:  Schizophr Bull       Date:  2015-07-17       Impact factor: 9.306

7.  Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition.

Authors:  Stefan Borgwardt; Nikolaos Koutsouleris; Jacqueline Aston; Erich Studerus; Renata Smieskova; Anita Riecher-Rössler; Eva M Meisenzahl
Journal:  Schizophr Bull       Date:  2012-09-11       Impact factor: 9.306

8.  Cortical Volume Differences in Subjects at Risk for Psychosis Are Driven by Surface Area.

Authors:  Roman Buechler; Diana Wotruba; Lars Michels; Anastasia Theodoridou; Sibylle Metzler; Susanne Walitza; Jürgen Hänggi; Spyros Kollias; Wulf Rössler; Karsten Heekeren
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

9.  Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication.

Authors:  Nathan L Hutcheson; David G Clark; Mark S Bolding; David M White; Adrienne C Lahti
Journal:  Psychiatry Res       Date:  2013-10-22       Impact factor: 3.222

10.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.